Nifurethazone
- Level
- Commodity
- Parent
- 51285300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51285312This classification denotes a topical anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 699M5Q0YKN. European Medicines Agency schedules Nifurethazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09264MIG. Nifurethazone generally arises in the molecular formula C10H15N5O4. The term NIFURETHAZONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, no. 3 1962, list 4.) NIFURETHAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nifurethazone under HS 29321900 and SITC 51569. As of Q4 2014, NIFURETHAZONE remains the US FDA Preferred Term for this commodity. Nifurethazone bears US NLM identifiers UMLS ID C2983964 and NCI Concept Code C90978. SMILES: CN(C)CCN(C(=O)N)/N=C/C1=CC=C(O1)[N+](=O)[O-].
Same parent
Under 51285300 · 19Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.